Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK/mTOR-mediated autophagy flux pathway. 2020

Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
Institute of Cardiovascular Development and Translational Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-exosomes) have been implicated as a novel therapeutic approach for tissue injury repair and regeneration, but the effects of hucMSC-exosomes on coxsackievirus B3 (CVB3)-induced myocarditis remain unknown. The object of the present study is to investigate whether hucMSC-exosomes have therapeutic effects on CVB3-induced myocarditis (VMC). HucMSC-exosomes were identified using nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM) and Western blot. The purified hucMSC-exosomes tagged with PKH26 were tail intravenously injected into VMC model mice in vivo and used to administrate CVB3-infected human cardiomyocytes (HCMs) in vitro, respectively. The effects of hucMSC-exosomes on myocardial pathology injury, proinflammatory cytokines and cardiac function were evaluated through haematoxylin and eosin (H&E) staining, quantitative polymerase chain reaction (qPCR) and Doppler echocardiography. The anti-apoptosis role and potential mechanism of hucMSC-exosomes were explored using TUNEL staining, flow cytometry, immunohistochemistry, Ad-mRFP-GFP-LC3 transduction and Western blot. In vivo results showed that hucMSC-exosomes (50 μg iv) significantly alleviated myocardium injury, shrank the production of proinflammatory cytokines and improved cardiac function. Moreover, in vitro data showed that hucMSC-exosomes (50 μg/mL) inhibited the apoptosis of CVB3-infected HCM through increasing pAMPK/AMPK ratio and up-regulating autophagy proteins LC3II/I, BECLIN-1 and anti-apoptosis protein BCL-2 as well as decreasing pmTOR/mTOR ratio, promoting the degradation of autophagy flux protein P62 and down-regulating apoptosis protein BAX. In conclusion, hucMSC-exosomes could alleviate CVB3-induced myocarditis via activating AMPK/mTOR-mediated autophagy flux pathway to attenuate cardiomyocyte apoptosis, which will be benefit for MSC-exosome therapy of myocarditis in the future.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D014470 Umbilical Cord The flexible rope-like structure that connects a developing FETUS to the PLACENTA in mammals. The cord contains blood vessels which carry oxygen and nutrients from the mother to the fetus and waste products away from the fetus. Cord, Umbilical,Cords, Umbilical,Umbilical Cords
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
March 2013, Stem cells and development,
Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
December 2022, Biochemical and biophysical research communications,
Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
January 2023, PeerJ,
Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
January 2022, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
September 2019, Journal of cellular biochemistry,
Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
January 2018, American journal of translational research,
Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
September 2021, Journal of pharmacological sciences,
Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
March 2024, Experimental cell research,
Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
October 2019, Chemosphere,
Xiaohong Gu, and Yuechun Li, and Kaixin Chen, and Xingang Wang, and Zhongyu Wang, and Hao Lian, and Yuanzheng Lin, and Xing Rong, and Maoping Chu, and Jiafeng Lin, and Xiaoling Guo
October 2023, Neural regeneration research,
Copied contents to your clipboard!